https://doi.org/10.4081/acbr.2021.99

Assessment of serum uric acid levels in patients with cervical intraepithelial neoplasia in Benin City

Vol. 2 No. 1 (2021)
Submitted: 9 August 2020
Accepted: 22 January 2021
Published: 2 February 2021
Cervix, cancer, uric acid, neoplasia, metabolic medicine
Abstract Views: 1935
PDF: 186
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Kenneth Atoe
atoe.kenneth@edouniversity.edu.ng
https://orcid.org/0000-0001-7638-6040
Department of Chemical Pathology, Edo University, Iyamho, Edo State; Applied Environmental Bioscience and Public Research Group, University of Benin, Benin City; Phytomedicine and Drug Discovery Research Group, Department of Plant Biology and Biotechnology, University of Benin, Benin City, Nigeria.
Augustine Onovuakpo Eguvbe
https://orcid.org/0000-0002-2722-2186
Department of Chemical Pathology, Edo University, Iyamho, Edo State, Nigeria.

Elevated Uric acid levels in humans have been associated with cancer, though the pathogenic mechanism is still unclear. The present study attempts to investigate if elevated uric acid levels could be used to investigate the pre-malignant lesions leading to cervical cancer. The study which was carried out at the Department of Obstetrics and Gynaecology, University of Benin Teaching Hospital Benin City and Department of Chemical Pathology, Edo University Iyamho, Edo state Nigeria, between August, 2017 and January 2019, examined the capacity of detecting Cervical Intraepithelial Neoplasia (CIN) early with serum uric acid in order to increase the chances of survival of women at risk. A total of 197 female participants were recruited for the study. Based on histological diagnosis, they were grouped as CIN 1, CIN 2 and CIN 3. The control group were negative for CIN. Venous blood was obtained from participants and serum uric acid levels were determined using standard laboratory methods. The benchmark for serum uric acid levels in diagnosing CIN presented in this study was at 6.55 mg/dL. The probability that uric acid level higher than 6.55 mg/dL indicate the disease probabilty was 93.1%. The age category within the CIN group with the highest level of uric acid was 31-40 years (10.86 mg/dL). The use of serum uric acid as an excellent biomarker for the diagnosis of CIN is therefore suggested due to its high sensitivity.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Pisani P, Parkin DM, Bray F, Ferley J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:870-3. DOI: https://doi.org/10.1002/(SICI)1097-0215(19991210)83:6<870::AID-IJC35>3.0.CO;2-9
Ahmed SA, Sabitu K, Idris SH, Ahmed R. Knowledge, attitude and practice of cervical cancer screening among market women in Zaria, Nigeria. Nigeria Med J 2013;54:316-9. DOI: https://doi.org/10.4103/0300-1652.122337
Parkin DM, Bray F, Ferlay J, Pisani P. Global center statistics, 2002. CA Cancer J Clin 2005;55:74–108. DOI: https://doi.org/10.3322/canjclin.55.2.74
Ostor, AG. Natural history of cervical intraepithelial neoplasia: A critical review. Int J Gynecol Pathol 1993;12:186‑92. DOI: https://doi.org/10.1097/00004347-199304000-00018
Wang S, Liu X, He Z, et al. Hyperuricemia has an adverse impact on the prognosis of patients with osteosarcoma. Tumour Biol 2018;37:1205–10. DOI: https://doi.org/10.1007/s13277-015-3830-3
Li C, Li Y, Su N, et al. Hyperuricemia predicts poor prognosis of patients with cervical cancer. Oncotarget 2018;9:537- 42. DOI: https://doi.org/10.18632/oncotarget.23589
Ara SA, Ashraf S, Patil BM. Evaluation of serum uric acid levels in patients with oral squamous cell carcinoma. Indian J Dent Res 2016;27:178–83. DOI: https://doi.org/10.4103/0970-9290.183128
Shin HS, Lee HR, Lee DC, et al. Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manag 2006;31:493–501. DOI: https://doi.org/10.1016/j.jpainsymman.2005.11.014
Zoppi F, Fenili D, Marcovina S, Peracino A. Aldehyde dehydrogenase interference in the Haeckel enzymic technique for uric acid determination. Clin Chem 1980;26:178. DOI: https://doi.org/10.1093/clinchem/26.1.178
Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Statistics Med 1994;13:499–508. DOI: https://doi.org/10.1002/sim.4780130513
Basu J, Mikhail MS, Ahn CH, et al. Plasma uric acid levels in women with cervical intraepithelial neoplasia. Nutrition Cancer 2005;51:25–31. DOI: https://doi.org/10.1207/s15327914nc5101_4
Yan S, Zhang P, Xu W, et al. Serum uric acid increases risk of cancer incidence and mortality: asystematic review and meta-analysis. Mediators Inflamm 2015;2015:764250. DOI: https://doi.org/10.1155/2015/764250
Yim K, Bindayi A, McKay R, et al. Rising serum uric acid level is negatively associated with survival in renal cell carcinoma. Cancers 2019;11:536. DOI: https://doi.org/10.3390/cancers11040536
Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87–114. DOI: https://doi.org/10.1124/pr.58.1.6
Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proceedings of the National Academy of Sciences of the United States of America 1981;78:6858–62. DOI: https://doi.org/10.1073/pnas.78.11.6858
Becker BF. Towards the physiological function of uric acid. Free Radical Biol Med 1993;14:615–31. DOI: https://doi.org/10.1016/0891-5849(93)90143-I

How to Cite

Atoe, K., & Eguvbe, A. O. (2021). Assessment of serum uric acid levels in patients with cervical intraepithelial neoplasia in Benin City. Annals of Clinical and Biomedical Research, 2(1). https://doi.org/10.4081/acbr.2021.99

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.